Complete pre-operative cardiac workup including coronary angiography, echocardiography, and pulmonary function tests. NPO for 8 hours. Baseline coagulation profile, type and screen blood, antibiotic prophylaxis, and placement of double-lumen endotracheal tube.
Immediate post-operative care in the Cardiothoracic ICU for hemodynamic monitoring. Management of chest drains, titration of anticoagulants, pain management, early mobilization within 24 hours, and transition to a step-down ward. Discharge planning focuses on sternal-sparing activity protocols, wound care, and follow-up cardiac imaging.
Comprehensive Clinical Guide: Totally Endoscopic Coronary Artery Bypass Grafting (TECAB)
1. Introduction and Clinical Overview
Totally Endoscopic Coronary Artery Bypass Grafting (TECAB) represents the pinnacle of minimally invasive cardiac surgery. Unlike traditional Coronary Artery Bypass Grafting (CABG), which requires a median sternotomy (splitting the breastbone), TECAB is performed through small intercostal ports using robotic assistance. This procedure is designed to revascularize the ischemic myocardium while minimizing the surgical trauma, blood loss, and recovery time associated with open-heart surgery.
In the modern landscape of cardiovascular medicine, TECAB serves as a sophisticated alternative for patients who require surgical revascularization but wish to avoid the long-term morbidity associated with sternal incision. By utilizing the da Vinci® Surgical System or similar robotic platforms, the surgeon gains high-definition, three-dimensional visualization and micro-instrument precision, allowing for the creation of intricate coronary anastomoses without the need for a large chest opening.
2. Technical Specifications and Mechanism
The core mechanism of TECAB relies on the integration of robotic telemanipulation and endoscopic visualization. The procedure is typically performed under general anesthesia with double-lumen endotracheal intubation, which allows for selective lung ventilation (collapsing the left lung) to provide the surgeon with an unobstructed view of the heart.
The Robotic Platform
The surgical team utilizes a master-slave robotic interface. The surgeon sits at a console away from the patient, manipulating hand controllers that translate movements into precise actions by robotic arms inserted into the patient’s chest.
Key Components of the Procedure
- Port Placement: Generally, three to four ports are placed on the left lateral chest wall.
- Endoscopic Visualization: A 30-degree high-definition camera provides the surgeon with a magnified, 3D view of the surgical field.
- Targeted Revascularization: The Left Internal Mammary Artery (LIMA) is harvested endoscopically and anastomosed to the Left Anterior Descending (LAD) artery.
- Cardiopulmonary Bypass (CPB): TECAB can be performed "on-pump" (using peripheral femoral cannulation for CPB) or "off-pump" (beating heart), depending on the surgeon’s preference and the patient’s clinical profile.
3. Clinical Indications and Patient Selection
TECAB is not a universal solution; it is a highly specialized procedure reserved for specific patient populations.
Indications
- Isolated LAD Disease: Patients with significant stenosis of the Left Anterior Descending artery.
- Multi-vessel Disease (in hybrid settings): Patients receiving a robotic LIMA-to-LAD graft followed by percutaneous coronary intervention (PCI) for other vessels.
- Patients at High Risk for Sternal Wound Complications: Such as obese patients, patients with diabetes, or those with chronic obstructive pulmonary disease (COPD).
- Cosmetic/Quality of Life Preferences: Patients seeking a faster return to daily activities and avoidance of sternal scarring.
Contraindications
- Severe Adhesions: Previous left-sided thoracic surgery or pleurodesis.
- Aortic Calcification: Significant porcelain aorta (if clamping is required).
- Hemodynamic Instability: Patients who require emergent surgery.
- Inadequate Vessel Anatomy: Small-caliber coronary arteries or unsuitable LIMA graft quality.
4. Pre-operative Preparation
Preparation for TECAB is rigorous and multidisciplinary.
| Phase | Action Items |
|---|---|
| Cardiac Imaging | Coronary CT Angiography (CCTA) to assess graft target and chest wall anatomy. |
| Pulmonary Assessment | Pulmonary Function Tests (PFTs) to ensure the patient can tolerate single-lung ventilation. |
| Vascular Assessment | Ultrasound of the femoral vessels to ensure safety for peripheral bypass cannulation. |
| Anesthesia Prep | Discussion regarding the use of single-lung ventilation and potential for conversion to sternotomy. |
5. The Procedure: Step-by-Step
Phase 1: Access and Setup
The patient is placed in a right lateral decubitus position. After the induction of anesthesia, the left lung is deflated. Ports are placed in the 3rd, 4th, and 6th intercostal spaces.
Phase 2: LIMA Harvesting
The robotic arms are docked. The surgeon identifies the LIMA and uses endoscopic cautery and shears to dissect the artery from the chest wall, ensuring it is prepared for the anastomosis.
Phase 3: Pericardiotomy and Target Exposure
The pericardium is opened, and the LAD artery is identified. If performing the surgery "on-pump," the femoral vessels are cannulated, and the patient is placed on bypass.
Phase 4: Anastomosis
This is the most critical step. The LIMA is sutured to the LAD. Robotic instruments allow for "wristed" motion, which facilitates the delicate suturing required for microvascular anastomosis.
Phase 5: Closure
Once the graft is checked for patency (using intraoperative transit-time flow measurement), the ports are closed, and a chest tube is placed.
6. Post-operative Recovery and Outcomes
Expected Recovery Protocol
- Extubation: Usually occurs within 4–6 hours post-op in the Intensive Care Unit (ICU).
- Mobilization: Patients are encouraged to sit up and walk within 24 hours.
- Chest Tube Management: Typically removed within 48–72 hours.
- Length of Stay: Average hospital stay is 3–5 days, significantly shorter than the 7–10 days for open CABG.
Typical Outcomes
- High Graft Patency: Studies indicate patency rates for robotic LIMA-LAD grafts are comparable to open LIMA-LAD grafts (>95% at one year).
- Reduced Morbidity: Lower rates of wound infection, blood transfusion, and atrial fibrillation.
- Pain Management: Reduced need for intravenous opioids compared to sternotomy.
7. Potential Complications
While TECAB is less invasive, it carries specific risks:
* Conversion to Sternotomy: The most significant risk; if visualization is poor or bleeding occurs, the surgeon must be prepared to convert to a traditional open procedure immediately.
* Intercostal Nerve Injury: Can lead to chronic chest wall pain or numbness.
* Phrenic Nerve Injury: Rare but can cause diaphragmatic paralysis.
* Graft Failure: Technical errors during anastomosis can lead to ischemia.
8. Alternative Treatments
| Procedure | Pros | Cons |
|---|---|---|
| Traditional CABG | Gold standard, easier access, well-studied. | Large scar, long recovery, sternal infection risk. |
| PCI (Stenting) | Minimally invasive, no incision. | Higher rate of repeat revascularization, stent restenosis. |
| MIDCAB | Less invasive than CABG, no robot needed. | Limited access to multiple vessels, larger incision than TECAB. |
9. Massive FAQ Section
1. Is TECAB considered "open-heart" surgery?
Yes, it is cardiac surgery performed on the heart, but it is not "open-chest" in the traditional sense, as the sternum remains intact.
2. How long does the robotic surgery take?
Typically, TECAB takes between 3 to 5 hours, depending on the complexity of the anatomy and the surgeon's experience level.
3. Does the robot perform the surgery by itself?
No. The robot is a tool. Every movement is controlled by the surgeon at the console.
4. What happens if the robot malfunctions?
Robotic systems have redundant safety features. If a system failure occurs, the surgeon can manually undock the robot and complete the procedure via a small incision or conversion to sternotomy.
5. Will I have a large scar?
No. You will have 3–4 small incisions (approx. 1–2 cm each), which are significantly less visible than a 20 cm midline sternotomy scar.
6. Can TECAB treat all types of heart blockages?
No. It is primarily indicated for patients with single or double-vessel disease involving the LAD. Complex multi-vessel disease usually requires traditional CABG.
7. How much pain will I be in after surgery?
Most patients report significantly less pain than traditional CABG, but some intercostal discomfort is common due to port placement.
8. How soon can I drive after TECAB?
Usually, patients are cleared to drive in 2–3 weeks, compared to 6–8 weeks for traditional open-heart surgery.
9. Is TECAB covered by insurance?
Most major insurance providers cover robotic cardiac surgery, but it is essential to verify with your provider and confirm the hospital’s robotic program status.
10. What is the long-term success rate?
Long-term outcomes for TECAB are excellent, showing sustained graft patency and survival rates equivalent to traditional surgical revascularization.
10. Conclusion
Totally Endoscopic CABG (TECAB) represents a significant advancement in the field of cardiovascular surgery. By merging the precision of robotic technology with the physiological benefits of minimally invasive access, it offers a compelling option for selected patients. While the learning curve for surgeons is steep and the patient selection criteria are strict, the benefits—reduced trauma, faster recovery, and high-quality revascularization—position TECAB as a vital component of modern, patient-centered cardiac care.
Patients considering this procedure should consult with a specialized cardiothoracic surgeon who has extensive experience in robotic cardiac platforms to determine if they are an ideal candidate for this technologically advanced intervention.